Skip to main content
Top
Published in: Child and Adolescent Psychiatry and Mental Health 1/2008

Open Access 01-12-2008 | Research

Impact of attention-deficit/hyperactivity disorder on the patient and family: results from a European survey

Authors: David Coghill, Cesar Soutullo, Carlos d'Aubuisson, Ulrich Preuss, Trygve Lindback, Maria Silverberg, Jan Buitelaar

Published in: Child and Adolescent Psychiatry and Mental Health | Issue 1/2008

Login to get access

Abstract

Background

Children with attention-deficit/hyperactivity disorder (ADHD) often experience problems with education, interaction with others and emotional disturbances. Families of ADHD children also suffer a significant burden, in terms of strain on relationships and reduced work productivity. This parent survey assessed daily life for children with ADHD and their families.

Method

This pan-European survey involved the completion of an on-line questionnaire by parents of children (6–18 years) with ADHD (ADHD sample) and without ADHD (normative population sample). Parents were questioned about the impact of their child's ADHD on everyday activities, general behaviour and family relationships.

Results

The ADHD sample comprised 910 parents and the normative population sample 995 parents. 62% of ADHD children were not currently receiving medication; 15% were receiving 6–8 hour stimulant medication and 23% 12-hour stimulant medication. Compared with the normative population sample, parents reported that ADHD children consistently displayed more demanding, noisy, disruptive, disorganised and impulsive behaviour. Significantly more parents reported that ADHD children experienced challenges throughout the day, from morning until bedtime, compared with the normative population sample. Parents reported that children with ADHD receiving 12-hour stimulant medication experienced fewer challenges during early afternoon and late afternoon/early evening than children receiving 6–8 hour stimulant medication; by late evening and bedtime however, this difference was not apparent. ADHD was reported to impact most significantly on activities such as homework, family routines and playing with other children. All relationships between ADHD children and others were also negatively affected, especially those between parent and child (72% of respondents). Parents reported that more children with ADHD experienced a personal injury in the preceding 12 months, including those requiring the attention of healthcare professionals. Although 68% of parents were satisfied with their child's current treatment, 35–40% stated that their child's ADHD symptoms needed to be more effectively treated during the afternoon and evening.

Conclusion

This parent survey highlights the breadth of problems experienced by ADHD children and the impact throughout the day on both activities and relationships. Therefore, there is a need for treatment approaches that take into account the 24-hour impact of the disorder and include all-day coverage with effective medication.
Appendix
Available only for authorised users
Literature
1.
go back to reference American Academy of Pediatrics: Clinical practice guidelines: diagnosis and evaluation of the child with attention-deficity/hyperactivity disorder. Pediatrics. 2000, 105: 1158-1170. 10.1542/peds.105.5.1158.CrossRef American Academy of Pediatrics: Clinical practice guidelines: diagnosis and evaluation of the child with attention-deficity/hyperactivity disorder. Pediatrics. 2000, 105: 1158-1170. 10.1542/peds.105.5.1158.CrossRef
2.
go back to reference Gaub M, Carlson C: Gender differences in ADHD: a meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry. 1997, 36: 1036-1045. 10.1097/00004583-199708000-00011.CrossRefPubMed Gaub M, Carlson C: Gender differences in ADHD: a meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry. 1997, 36: 1036-1045. 10.1097/00004583-199708000-00011.CrossRefPubMed
3.
go back to reference Greene RW, Biederman J, Faraone SV, Ouellette CA, Penn C, Griffin SM: Toward a new psychometric definition of social disability in children with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1996, 35: 571-578. 10.1097/00004583-199605000-00011.CrossRefPubMed Greene RW, Biederman J, Faraone SV, Ouellette CA, Penn C, Griffin SM: Toward a new psychometric definition of social disability in children with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1996, 35: 571-578. 10.1097/00004583-199605000-00011.CrossRefPubMed
4.
go back to reference Stein MA, Szumowski E, Blondis TA, Roizen NJ: Adaptive skills dysfunction in ADD and ADHD children. J Child Psychol Psychiatry. 1995, 36: 663-670.CrossRefPubMed Stein MA, Szumowski E, Blondis TA, Roizen NJ: Adaptive skills dysfunction in ADD and ADHD children. J Child Psychol Psychiatry. 1995, 36: 663-670.CrossRefPubMed
5.
go back to reference Biederman J, Faraone SV, Spencer T, Wilens T, Norman D, Lapey KA, Mick E, Lehman BK, Doyle A: Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 1993, 150: 1792-1798.CrossRefPubMed Biederman J, Faraone SV, Spencer T, Wilens T, Norman D, Lapey KA, Mick E, Lehman BK, Doyle A: Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 1993, 150: 1792-1798.CrossRefPubMed
6.
go back to reference Biederman J, Faraone SV, Taylor A, Sienna M, Williamson S, Fine C: Diagnostic continuity between child and adolescent ADHD: findings from a longitudinal clinical sample. J Am Acad Child Adolesc Psychiatry. 1998, 37: 305-313.CrossRefPubMed Biederman J, Faraone SV, Taylor A, Sienna M, Williamson S, Fine C: Diagnostic continuity between child and adolescent ADHD: findings from a longitudinal clinical sample. J Am Acad Child Adolesc Psychiatry. 1998, 37: 305-313.CrossRefPubMed
7.
go back to reference Wilens TE, Biederman J, Spencer TJ: Attention deficit/hyperactivity disorder across the lifespan. Annu Rev Med. 2002, 53: 113-131. 10.1146/annurev.med.53.082901.103945.CrossRefPubMed Wilens TE, Biederman J, Spencer TJ: Attention deficit/hyperactivity disorder across the lifespan. Annu Rev Med. 2002, 53: 113-131. 10.1146/annurev.med.53.082901.103945.CrossRefPubMed
8.
go back to reference Biederman J, Faraone S, Milberger S, Guite J, Mick E, Chen L, Mennin D, Marrs A, Ouellette C, Moore P, Spencer T, Norman D, Wilens T, Kraus I, Perrin J: A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Arch Gen Psychiatry. 1996, 53: 437-446.CrossRefPubMed Biederman J, Faraone S, Milberger S, Guite J, Mick E, Chen L, Mennin D, Marrs A, Ouellette C, Moore P, Spencer T, Norman D, Wilens T, Kraus I, Perrin J: A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Arch Gen Psychiatry. 1996, 53: 437-446.CrossRefPubMed
9.
go back to reference Barkley RA, Fischer M, Edelbrock CS, Smallish L: The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry. 1990, 29: 546-557. 10.1097/00004583-199007000-00007.CrossRefPubMed Barkley RA, Fischer M, Edelbrock CS, Smallish L: The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry. 1990, 29: 546-557. 10.1097/00004583-199007000-00007.CrossRefPubMed
10.
go back to reference Biederman J, Mick E, Faraone SV: Normalized functioning in youths with persistent attention-deficit/hyperactivity disorder. J Pediatr. 1998, 133: 544-551. 10.1016/S0022-3476(98)70065-4.CrossRefPubMed Biederman J, Mick E, Faraone SV: Normalized functioning in youths with persistent attention-deficit/hyperactivity disorder. J Pediatr. 1998, 133: 544-551. 10.1016/S0022-3476(98)70065-4.CrossRefPubMed
11.
go back to reference DiScala C, Lescohier I, Barthel M, Li G: Injuries to children with attention deficit hyperactivity disorder. Pediatrics. 1998, 102: 1415-1421. 10.1542/peds.102.6.1415.CrossRefPubMed DiScala C, Lescohier I, Barthel M, Li G: Injuries to children with attention deficit hyperactivity disorder. Pediatrics. 1998, 102: 1415-1421. 10.1542/peds.102.6.1415.CrossRefPubMed
12.
go back to reference Jensen PS, Shervette RE, Xenakis SN, Bain MW: Psychosocial and medical histories of stimulant-treated children. J Am Acad Child Adolesc Psychiatry. 1988, 27: 798-801.CrossRefPubMed Jensen PS, Shervette RE, Xenakis SN, Bain MW: Psychosocial and medical histories of stimulant-treated children. J Am Acad Child Adolesc Psychiatry. 1988, 27: 798-801.CrossRefPubMed
13.
go back to reference Anderson JC, Williams S, McGee R, Silva PA: DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population. Arch Gen Psychiatry. 1987, 44: 69-76.CrossRefPubMed Anderson JC, Williams S, McGee R, Silva PA: DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population. Arch Gen Psychiatry. 1987, 44: 69-76.CrossRefPubMed
14.
go back to reference Bird HR, Gould MS, Staghezza BM: Patterns of diagnostic comorbidity in a community sample of children aged 9 through 16 years. J Am Acad Child Adolesc Psychiatry. 1993, 32: 361-368. 10.1097/00004583-199303000-00018.CrossRefPubMed Bird HR, Gould MS, Staghezza BM: Patterns of diagnostic comorbidity in a community sample of children aged 9 through 16 years. J Am Acad Child Adolesc Psychiatry. 1993, 32: 361-368. 10.1097/00004583-199303000-00018.CrossRefPubMed
15.
go back to reference Biederman J, Newcorn J, Sprich S: Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry. 1991, 148: 564-577.CrossRefPubMed Biederman J, Newcorn J, Sprich S: Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry. 1991, 148: 564-577.CrossRefPubMed
16.
go back to reference Biederman J, Wilens TE, Mick E, Faraone SV, Spencer T: Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence?. Biol Psychiatry. 1998, 44: 269-273. 10.1016/S0006-3223(97)00406-X.CrossRefPubMed Biederman J, Wilens TE, Mick E, Faraone SV, Spencer T: Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence?. Biol Psychiatry. 1998, 44: 269-273. 10.1016/S0006-3223(97)00406-X.CrossRefPubMed
17.
go back to reference Pomerleau OF, Downey KK, Stelson FW, Pomerleau CS: Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. J Subst Abuse. 1995, 7: 373-378. 10.1016/0899-3289(95)90030-6.CrossRefPubMed Pomerleau OF, Downey KK, Stelson FW, Pomerleau CS: Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. J Subst Abuse. 1995, 7: 373-378. 10.1016/0899-3289(95)90030-6.CrossRefPubMed
18.
go back to reference Milberger S, Biederman J, Faraone SV, Chen L, Jones J: ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1997, 36: 37-44. 10.1097/00004583-199701000-00015.CrossRefPubMed Milberger S, Biederman J, Faraone SV, Chen L, Jones J: ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1997, 36: 37-44. 10.1097/00004583-199701000-00015.CrossRefPubMed
19.
go back to reference Brown R, Pacinin J: Perceived family functioning, marital status and depression in parents of boys with attention deficit disorder. J Learn Disabil. 1989, 22: 581-587.CrossRefPubMed Brown R, Pacinin J: Perceived family functioning, marital status and depression in parents of boys with attention deficit disorder. J Learn Disabil. 1989, 22: 581-587.CrossRefPubMed
20.
go back to reference Noe L, Hankin C: Health outcomes of childhood attention-deficit/hyperactivity disorder (ADHD): Health care use and work status of caregivers. Value Health. 2001, 4: 142-143. 10.1046/j.1524-4733.2001.40202-196.x.CrossRef Noe L, Hankin C: Health outcomes of childhood attention-deficit/hyperactivity disorder (ADHD): Health care use and work status of caregivers. Value Health. 2001, 4: 142-143. 10.1046/j.1524-4733.2001.40202-196.x.CrossRef
21.
go back to reference Pelham WE, Foster EM, Robb JA: The economic impact of attention-deficit/hyperactivity disorder in children and adolescents. J Pediatr Psychol. 2007, 32: 711-727. 10.1093/jpepsy/jsm022.CrossRefPubMed Pelham WE, Foster EM, Robb JA: The economic impact of attention-deficit/hyperactivity disorder in children and adolescents. J Pediatr Psychol. 2007, 32: 711-727. 10.1093/jpepsy/jsm022.CrossRefPubMed
22.
go back to reference Hakkaart-van Roijen L, Zwirs BW, Bouwmans C, Tan SS, Schulpen TW, Vlasveld L, Buitelaar JK: Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry. 2007, 16: 316-326. 10.1007/s00787-007-0603-6.CrossRefPubMed Hakkaart-van Roijen L, Zwirs BW, Bouwmans C, Tan SS, Schulpen TW, Vlasveld L, Buitelaar JK: Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry. 2007, 16: 316-326. 10.1007/s00787-007-0603-6.CrossRefPubMed
23.
go back to reference Leibson CL, Katusic SK, Barbaresi WJ, Ransom J, O'Brien PC: Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. Jama. 2001, 285: 60-66. 10.1001/jama.285.1.60.CrossRefPubMed Leibson CL, Katusic SK, Barbaresi WJ, Ransom J, O'Brien PC: Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. Jama. 2001, 285: 60-66. 10.1001/jama.285.1.60.CrossRefPubMed
24.
go back to reference Greenhill LL, Halperin JM, Abikoff H: Stimulant medications. J Am Acad Child Adolesc Psychiatry. 1999, 38: 503-512. 10.1097/00004583-199905000-00011.CrossRefPubMed Greenhill LL, Halperin JM, Abikoff H: Stimulant medications. J Am Acad Child Adolesc Psychiatry. 1999, 38: 503-512. 10.1097/00004583-199905000-00011.CrossRefPubMed
25.
go back to reference Spencer T, Biederman J, Wilens T, Harding M, O'Donnell D, Griffin S: Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry. 1996, 35: 409-432.CrossRefPubMed Spencer T, Biederman J, Wilens T, Harding M, O'Donnell D, Griffin S: Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry. 1996, 35: 409-432.CrossRefPubMed
26.
go back to reference Taylor E, Dopfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga-Barke E, Steinhausen HC, Zuddas A: European clinical guidelines for hyperkinetic disorder – first upgrade. Eur Child Adolesc Psychiatry. 2004, 13 Suppl 1: I7-30.PubMed Taylor E, Dopfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga-Barke E, Steinhausen HC, Zuddas A: European clinical guidelines for hyperkinetic disorder – first upgrade. Eur Child Adolesc Psychiatry. 2004, 13 Suppl 1: I7-30.PubMed
27.
go back to reference Pelham WE, Gnagy EM, Burrows-Maclean L, Williams A, Fabiano GA, Morrisey SM, Chronis AM, Forehand GL, Nguyen CA, Hoffman MT, Lock TM, Fielbelkorn K, Coles EK, Panahon CJ, Steiner RL, Meichenbaum DL, Onyango AN, Morse GD: Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics. 2001, 107: E105-10.1542/peds.107.6.e105.CrossRefPubMed Pelham WE, Gnagy EM, Burrows-Maclean L, Williams A, Fabiano GA, Morrisey SM, Chronis AM, Forehand GL, Nguyen CA, Hoffman MT, Lock TM, Fielbelkorn K, Coles EK, Panahon CJ, Steiner RL, Meichenbaum DL, Onyango AN, Morse GD: Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics. 2001, 107: E105-10.1542/peds.107.6.e105.CrossRefPubMed
28.
go back to reference Swanson J, Gupta S, Lam A, Shoulson I, Lerner M, Modi N, Lindemulder E, Wigal S: Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies. Arch Gen Psychiatry. 2003, 60: 204-211. 10.1001/archpsyc.60.2.204.CrossRefPubMed Swanson J, Gupta S, Lam A, Shoulson I, Lerner M, Modi N, Lindemulder E, Wigal S: Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies. Arch Gen Psychiatry. 2003, 60: 204-211. 10.1001/archpsyc.60.2.204.CrossRefPubMed
29.
go back to reference Favreau A, Deseille-Turlotte G, Brault F, Giraudeau B, Krier C, Barthez MA, Castelnau P: [Benefit of the extended-release methylphenidate formulations: a comparative study in childhood]. Arch Pediatr. 2006, 13: 442-448. 10.1016/j.arcped.2006.02.004.CrossRefPubMed Favreau A, Deseille-Turlotte G, Brault F, Giraudeau B, Krier C, Barthez MA, Castelnau P: [Benefit of the extended-release methylphenidate formulations: a comparative study in childhood]. Arch Pediatr. 2006, 13: 442-448. 10.1016/j.arcped.2006.02.004.CrossRefPubMed
30.
go back to reference Biederman J, Quinn D, Weiss M, Markabi S, Weidenman M, Edson K, Karlsson G, Pohlmann H, Wigal S: Efficacy and safety of Ritalin LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorder. Paediatr Drugs. 2003, 5: 833-841. 10.2165/00148581-200305120-00006.CrossRefPubMed Biederman J, Quinn D, Weiss M, Markabi S, Weidenman M, Edson K, Karlsson G, Pohlmann H, Wigal S: Efficacy and safety of Ritalin LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorder. Paediatr Drugs. 2003, 5: 833-841. 10.2165/00148581-200305120-00006.CrossRefPubMed
31.
go back to reference Marcus SC, Wan GJ, Kemner JE, Olfson M: Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2005, 159: 572-578. 10.1001/archpedi.159.6.572.CrossRefPubMed Marcus SC, Wan GJ, Kemner JE, Olfson M: Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2005, 159: 572-578. 10.1001/archpedi.159.6.572.CrossRefPubMed
32.
go back to reference The MTA Cooperative Group: A 14-month randomised clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999, 56: 1073-1086. 10.1001/archpsyc.56.12.1073.CrossRef The MTA Cooperative Group: A 14-month randomised clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999, 56: 1073-1086. 10.1001/archpsyc.56.12.1073.CrossRef
33.
go back to reference Wilens TE, Faraone SV, Biederman J, Gunawardene S: Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics. 2003, 111: 179-185. 10.1542/peds.111.1.179.CrossRefPubMed Wilens TE, Faraone SV, Biederman J, Gunawardene S: Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics. 2003, 111: 179-185. 10.1542/peds.111.1.179.CrossRefPubMed
34.
go back to reference Prasad S, Steer C: Switching from neurostimulant therapy to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder: clinical approaches and review of current available evidence. Paediatr Drugs. 2008, 10: 39-47. 10.2165/00148581-200810010-00005.CrossRefPubMed Prasad S, Steer C: Switching from neurostimulant therapy to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder: clinical approaches and review of current available evidence. Paediatr Drugs. 2008, 10: 39-47. 10.2165/00148581-200810010-00005.CrossRefPubMed
35.
go back to reference Bangs ME, Hazell P, Danckaerts M, Hoare P, Coghill DR, Wehmeier PM, Williams DW, Moore RJ, Levine L: Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder. Pediatrics. 2008, 121: e314-320. 10.1542/peds.2006-1880.CrossRefPubMed Bangs ME, Hazell P, Danckaerts M, Hoare P, Coghill DR, Wehmeier PM, Williams DW, Moore RJ, Levine L: Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder. Pediatrics. 2008, 121: e314-320. 10.1542/peds.2006-1880.CrossRefPubMed
36.
go back to reference Bakken RJ, Paczkowski M, Kramer HP, Axelson AA, Williams DW, Malcolm SK, Sumner CR, Kelsey DK: Effects of atomoxetine on attention-deficit/hyperactivity disorder in clinical pediatric treatment settings: a naturalistic study. Curr Med Res Opin. 2008, 24: 449-460. 10.1185/030079908X253627.CrossRefPubMed Bakken RJ, Paczkowski M, Kramer HP, Axelson AA, Williams DW, Malcolm SK, Sumner CR, Kelsey DK: Effects of atomoxetine on attention-deficit/hyperactivity disorder in clinical pediatric treatment settings: a naturalistic study. Curr Med Res Opin. 2008, 24: 449-460. 10.1185/030079908X253627.CrossRefPubMed
37.
go back to reference Perring C: Medicating children: the case of Ritalin. Bioethics. 1997, 11: 228-240. 10.1111/1467-8519.00061.CrossRefPubMed Perring C: Medicating children: the case of Ritalin. Bioethics. 1997, 11: 228-240. 10.1111/1467-8519.00061.CrossRefPubMed
38.
go back to reference Pelham WE, Wheeler T, Chronis A: Empirically supported psychosocial treatments for attention deficit hyperactivity disorder. J Clin Child Psychol. 1998, 27: 190-205. 10.1207/s15374424jccp2702_6.CrossRefPubMed Pelham WE, Wheeler T, Chronis A: Empirically supported psychosocial treatments for attention deficit hyperactivity disorder. J Clin Child Psychol. 1998, 27: 190-205. 10.1207/s15374424jccp2702_6.CrossRefPubMed
39.
go back to reference Pelham WE, Fabino GA, Massetti GM: Evidence-based assessment of attention deficit hyperactivity disorder in children and adolescents. J Clin Child Adolesc Psychol. 2005, 34 (3): 449-76. 10.1207/s15374424jccp3403_5.CrossRefPubMed Pelham WE, Fabino GA, Massetti GM: Evidence-based assessment of attention deficit hyperactivity disorder in children and adolescents. J Clin Child Adolesc Psychol. 2005, 34 (3): 449-76. 10.1207/s15374424jccp3403_5.CrossRefPubMed
40.
go back to reference Evans SW, Schultz BK, Sadler JM: Psychosocial interventions used to treat children with ADHD: safety and efficacy. J Psychosoc Nurs Ment Health Serv. 2008, 46: 49-57.CrossRefPubMed Evans SW, Schultz BK, Sadler JM: Psychosocial interventions used to treat children with ADHD: safety and efficacy. J Psychosoc Nurs Ment Health Serv. 2008, 46: 49-57.CrossRefPubMed
41.
go back to reference Knight LA, Rooney M, Chronis-Tuscano A: Psychosocial treatments for attention-deficit/hyperactivity disorder. Curr Psychiatry Rep. 2008, 10: 412-418. 10.1007/s11920-008-0066-6.CrossRefPubMed Knight LA, Rooney M, Chronis-Tuscano A: Psychosocial treatments for attention-deficit/hyperactivity disorder. Curr Psychiatry Rep. 2008, 10: 412-418. 10.1007/s11920-008-0066-6.CrossRefPubMed
42.
go back to reference Chronis AM, Jones HA, Raggi Vl: Evidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder. Clin Psychol Rev. 2006, 26: 486-502. 10.1016/j.cpr.2006.01.002.CrossRefPubMed Chronis AM, Jones HA, Raggi Vl: Evidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder. Clin Psychol Rev. 2006, 26: 486-502. 10.1016/j.cpr.2006.01.002.CrossRefPubMed
43.
go back to reference Danforth JS, Harvey E, Ulaszek WR, McKee TE: The outcomes of group parent training for families of children with attention-deficit hyperactivity disorder and defiant/aggressive behaviour. J Behav Ther Exp Psychiatry. 2006, 37: 188-205. 10.1016/j.jbtep.2005.05.009.CrossRefPubMed Danforth JS, Harvey E, Ulaszek WR, McKee TE: The outcomes of group parent training for families of children with attention-deficit hyperactivity disorder and defiant/aggressive behaviour. J Behav Ther Exp Psychiatry. 2006, 37: 188-205. 10.1016/j.jbtep.2005.05.009.CrossRefPubMed
44.
go back to reference Kutcher S, Aman M, Brooks SJ, Buitelaar J, van Daalen E, Fegert J, Findling RL, Fisman S, Greenhill LL, Huss M, Kusumakar V, Pine D, Taylor E, Tyano S: International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions. Eur Neuropsychopharmacol. 2004, 14: 11-28. 10.1016/S0924-977X(03)00045-2.CrossRefPubMed Kutcher S, Aman M, Brooks SJ, Buitelaar J, van Daalen E, Fegert J, Findling RL, Fisman S, Greenhill LL, Huss M, Kusumakar V, Pine D, Taylor E, Tyano S: International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions. Eur Neuropsychopharmacol. 2004, 14: 11-28. 10.1016/S0924-977X(03)00045-2.CrossRefPubMed
45.
go back to reference Wolraich ML, Greenhill LL, Pelham W, Swanson J, Wilens T, Palumbo D, Atkins M, McBurnett K, Bukstein O, August G: Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder. Pediatrics. 2001, 108: 883-892. 10.1542/peds.108.4.883.CrossRefPubMed Wolraich ML, Greenhill LL, Pelham W, Swanson J, Wilens T, Palumbo D, Atkins M, McBurnett K, Bukstein O, August G: Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder. Pediatrics. 2001, 108: 883-892. 10.1542/peds.108.4.883.CrossRefPubMed
Metadata
Title
Impact of attention-deficit/hyperactivity disorder on the patient and family: results from a European survey
Authors
David Coghill
Cesar Soutullo
Carlos d'Aubuisson
Ulrich Preuss
Trygve Lindback
Maria Silverberg
Jan Buitelaar
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Child and Adolescent Psychiatry and Mental Health / Issue 1/2008
Electronic ISSN: 1753-2000
DOI
https://doi.org/10.1186/1753-2000-2-31

Other articles of this Issue 1/2008

Child and Adolescent Psychiatry and Mental Health 1/2008 Go to the issue